I cannot provide an accurate gene function summary for KCP (kielin cysteine rich BMP regulator) based on the provided abstracts. None of the PubMed abstracts supplied contain information about KCP's biological function, mechanism, or disease relevance. The abstracts discuss unrelated topics including tirzepatide for pediatric diabetes 1, chr7 pruritus management 2, chr7 prurigo 3, sensitive skin 4, tenapanor for hyperphosphatemia 5, chr7 prurigo treatment 6, Kaposi's sarcoma-associated herpesvirus complement control protein 7, and prurigo nodularis immune signatures 8. While the NCBI summary indicates KCP enhances BMP signaling and inhibits activin-A and TGFB1 pathways, and GO annotations confirm extracellular localization with positive regulation of BMP signaling, these sources are not grounded in the provided PubMed literature. To generate a properly cited summary, abstracts directly investigating KCP's molecular function, signaling mechanisms, and clinical disease associations would be required.